National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 8,254 cases where Age is Unknown and Vaccine targets COVID-19 (COVID19) and Symptom is Acute endocarditis or Atypical mycobacterium pericarditis or Autoimmune myocarditis or Bacterial pericarditis or Carditis or Endocarditis or Endocarditis bacterial or Endocarditis enterococcal or Endocarditis noninfective or Endocarditis staphylococcal or Endocarditis viral or Eosinophilic myocarditis or Fungal endocarditis or Giant cell myocarditis or Immune-mediated myocarditis or Lupus endocarditis or Lyme carditis or Meningococcal carditis or Myocarditis or Myocarditis bacterial or Myocarditis infectious or Myocarditis septic or Myopericarditis or Pericarditis or Pericarditis constrictive or Pericarditis infective or Pericarditis lupus or Pericarditis meningococcal or Pericarditis rheumatic or Pericarditis tuberculous or Pleuropericarditis or Purulent pericarditis or Streptococcal endocarditis or Subacute endocarditis or Viral myocarditis or Viral pericarditis

Government Disclaimer on use of this data



Case Details

This is page 26 out of 826

Result pages: prev   17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35   next


VAERS ID: 1039741 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Myocarditis, Pericarditis
SMQs:, Systemic lupus erythematosus (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ILPFIZER INC2021123240

Write-up: Myocarditis; Pericarditis; This is a spontaneous report from a contactable consumer. This is the third of 5 cases reported under the scope of MOH Israel & Pfizer COVID-19 weekly meeting (a few adverse events were reported on Coronavirus vaccine). A male patient of an unspecified age (reported as 19, unit: unknown) received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration, on an unspecified date at single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. On an unspecified date, the patient experienced myocarditis and pericarditis and was hospitalized on an unspecified date. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.; Sender''s Comments: Linked Report(s) : IL-PFIZER INC-2021123239 same reporter/drug/events, different patients;IL-PFIZER INC-2021123238 same reporter/drug, different patient/events


VAERS ID: 1039803 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-07
Onset:2021-01-08
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1484 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Myocarditis
SMQs:, Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021126263

Write-up: hospitalization for acute myopericarditis; This is a spontaneous report from a contactable physician downloaded from the regulatory authority- IT-MINISAL02-666855. A 57-year-old male patient received the first dose of bnt162b2 (COMIRNATY, lot number: EL1484, expiration date: 30Apr2021), intramuscular on 07Jan2021 at 0.3 mL, single for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced hospitalization for acute myopericarditis on 08Jan2021 with outcome of recovering. Therapeutic measures were taken as a result of acute myopericarditis. No follow-up attempts possible. No further information expected.


VAERS ID: 1047854 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-27
Onset:2021-02-01
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6797 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Myocarditis, Pericarditis
SMQs:, Systemic lupus erythematosus (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19
Allergies:
Diagnostic Lab Data:
CDC Split Type: DEPFIZER INC2021127073

Write-up: Peri-/myokarditis/Pericarditis; Myocarditis; This is a spontaneous report from a non-contactable physician downloaded from the Medicines Agency (EMA) EudraVigilance- WEB [DE-PEI-PEI2021002080] received via Regulatory Authority. A 24-year-old male patient received the second dose of BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, lot numbe: EJ6797), intramuscular on 27Jan2021 at a single dose for COVID-19 immunisation. Medical history included covid-19 from Nov2020 to an unknown date. The patient''s concomitant medications were not reported. The patient previously received BNT162B2 (COMIRNATY) on 06Jan2021 for COVID-19 immunisation. The patient experienced peri-/myokarditis/pericarditis and myocarditis on 01Feb2021. Clinical course was as follows: Patient with Covid infection in early November 2020. Later vaccination on 06Jan2021 and second dose on 27Jan2021 with clinical and echocardiographic pericarditis. The following differential diagnoses were excluded: acute coronary syndrome / pulmonary artery embolism, aortic syndrome. Pericardial effusion, typical symptoms. Therapeutic measures were taken as a result of peri-/myokarditis/pericarditis and myocarditis. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1048057 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-21
Onset:2021-02-01
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood test, Chest X-ray, Chest pain, Dyspnoea, Electrocardiogram, Non-cardiac chest pain, Pericarditis
SMQs:, Anaphylactic reaction (broad), Systemic lupus erythematosus (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Pericarditis
Allergies:
Diagnostic Lab Data: Test Name: bloods; Result Unstructured Data: Test Result:normal; Test Name: chest x ray; Result Unstructured Data: Test Result:normal; Test Name: ECG; Result Unstructured Data: Test Result:normal
CDC Split Type: GBPFIZER INC2021132432

Write-up: Chest pain (non-cardiac); breathlessness; chest pain; pericarditis; This is a spontaneous report from a contactable other healthcare professional. This is a report received from the Regulatory Authority. Regulatory authority report number GB-MHRA-WEBCOVID-202102071031507810, Safety Report Unique Identifier GB-MHRA-ADR 24715380. A 49-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Jan2021 at single dose for covid-19 immunization. Medical history included pericarditis. The patient''s concomitant medications were not reported. The patient experienced breathlessness (medically significant) in 2021 with outcome of unknown , chest pain (medically significant) in 2021 with outcome of unknown, pericarditis (medically significant) in 2021 with outcome of unknown, chest pain (non-cardiac) (medically significant) on 01Feb2021 with outcome of not recovered. The patient underwent lab tests included blood test: normal, chest x-ray: normal, electrocardiogram: normal all on an unknown date. It was reported 2 weeks after first COVID vaccine, breathlessness and chest pain becoming increased. Patient had not tested positive for COVID-19 since having the vaccine. Patient had not had symptoms associated with COVID-19 and not had a COVID-19 test. Patient was not enrolled in clinical trial. Patient was not pregnant. No follow-up attempts are possible; information about lot/batch number cannot be obtained.


VAERS ID: 1048221 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-11
Onset:2021-01-14
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood lactic acid, Inflammatory marker test, Multiple organ dysfunction syndrome, Myocarditis, Septic shock
SMQs:, Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Sepsis (narrow), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-16
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19 (not hospitalized)
Allergies:
Diagnostic Lab Data: Test Date: 202101; Test Name: Lactate values; Result Unstructured Data: Test Result:increased; Test Date: 202101; Test Name: Inflammation values; Result Unstructured Data: Test Result:increased
CDC Split Type: ATPFIZER INC2021164871

Write-up: Septic shock; extensive myo- and pericarditis; Multiple organ failure despite hemofiltration; This is a spontaneous report from a contactable pharmacist downloaded from the Agency Regulatory Authority-WEB AT-BASGAGES-2021-02122. An 81-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 11Jan2021 at single dose for covid-19 immunisation. Medical history included covid-19 not ongoing not hospitalized. The patient''s concomitant medications were not reported. The patient experienced septic shock, extensive myo- and pericarditis, multiple organ failure despite hemofiltration on 14Jan2021. The events were fatal. The patient underwent lab tests and procedures which included Lactate values and Inflammation values: increased in Jan2021. The patient died on 16Jan2021. An autopsy was performed that revealed carditis pericardium myocardium. Comirnaty/ all events/ Primary source/ Certain. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Septic shock; extensive myo- and pericarditis; Multiple organ failure despite hemofiltration; Autopsy-determined Cause(s) of Death: Carditis pericardium myocardium


VAERS ID: 1048413 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-27
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood test, Dyspnoea, Heart rate increased, Myocarditis, Pain in extremity
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-02-01
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: blood tests; Result Unstructured Data: Test Result:heart inflammation
CDC Split Type: ILPFIZER INC2021170222

Write-up: myocarditis- inflammation of the heart muscle; accelerated heartbeat; shortness of breath; sharp pains that were radiating down his left arm; This is a spontaneous report from two contactable consumers. A 19-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 27Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient developed myocarditis on unspecified date and died on 01Feb2021 five days after second dose. Patient had no underlying medical conditions prior to the event. Patient was hospitalized in ICU with myocarditis - inflammation of the heart muscle, five days after receiving his second dose of the coronavirus vaccine. The young patient received treatment at a (PRIVACY) clinical center on Sunday night before being transferred for further treatment to (PRIVACY) Medical Center. From when he had received the second dose, he had experienced an accelerated heartbeat, along with shortness of breath and sharp pains that were radiating down his left arm on unspecified date. Lab data included blood tests on unspecified date that revealed the heart inflammation. The patient died on 01Feb2021. It was unknown if autopsy was performed. According to the clinic, it has still not been confirmed that the inflammation was developed as a side effect of the vaccination. However, a number of COVID-19-related myocarditis cases have been reported, according to the Institute of Health. Information on the lot/batch number has been requested.; Reported Cause(s) of Death: Myocarditis


VAERS ID: 1048632 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-11
Onset:2021-01-22
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Pericarditis, SARS-CoV-2 test
SMQs:, Systemic lupus erythematosus (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210111; Test Name: PCR for SARS-CoV-2 infection; Test Result: Negative
CDC Split Type: ROPFIZER INC2021164207

Write-up: Postvaccination pericarditis; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB RO-NMA-2021-SP39551. A 36-year-old female patient received the first dose of bnt162b2 (COMIRNATY), via an unspecified route of administration on 11Jan2021 at single dose for active immunisation. The patient medical history was not reported. There were no concomitant medications. On 22Jan2021, the physician developed postvaccination pericarditis. As a corrective therapy the patient received colchicine, ibuprofen (NUROFEN FORTE), vitamin C and magnesium. Withdrawal was not applicable because the administration has been completed. At the time of reporting, the outcome was not recovered. In the reporter''s opinion the event was related to bnt162b2. The patient has been tested for SARS-CoV-2 infection (negative PCR on 11Jan2021). The patient had no symptoms associated with COVID-19 before or after vaccination. The physician comments: "Clinically healthy and without a relevant personal medical history prior to vaccination." The adverse reaction was assessed as life threatening by the primary reporter. No follow-up attempts are possible. No further information expected. Information on batch/lot number cannot be obtained.


VAERS ID: 1050913 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-14
Onset:2021-01-22
   Days after vaccination:8
Submitted: 0000-00-00
Entered: 2021-02-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6797 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Chest pain, Pericarditis
SMQs:, Systemic lupus erythematosus (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021142240

Write-up: DOSE 1 VACCINE: retrosternal pain, diagnosis in the emergency room of pericarditis with involvement of the myocardium; DOSE 1 VACCINE: retrosternal pain, diagnosis in the emergency room of pericarditis with involvement of the myocardium; This is a spontaneous report from a contactable physician downloaded from the Agency-WEB IT-MINISAL02-671516. A 55-year-old male patient received the first dose of BNT162B2 (COMIRNATY, lot number: EJ6797, expiration date: 30Apr2021), intramuscularly on 14Jan2021 10:55 at single dose for covid-19 vaccination. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient received the first dose of vaccine diluted with 1.8 ml of 0.9% NaCl (lot 19PMA110 expiration date 11/2023) on 14Jan2021 at 10.55 am. On 22Jan2021 the patient went to emergency room for retrosternal pain where he was diagnosed with pericarditis involving the myocardium. Events were required hospitalization. Currently therapy with colchicine, ibuprofen, beta blocker (metoprolol), antihypertensive (ramipril), aspirin and pantoprazole for three months. The outcome of the events was recovering. No follow-up attempts possible. No further information expected.


VAERS ID: 1050958 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-20
Onset:2021-01-22
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-02-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1484 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Myocarditis, SARS-CoV-1 test
SMQs:, Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: LANSOPRAZOLE; ESCITALOPRAM; DOGMATIL; SEDOXIL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Depression; Dyslipidemia; Gastritis; Hyperuricaemia; Shellfish allergy
Allergies:
Diagnostic Lab Data: Test Date: 20210123; Test Name: SARS-CoV-1 test; Test Result: Negative
CDC Split Type: PTPFIZER INC2021141150

Write-up: perimyocarditis; This is a spontaneous report from a contactable physician downloaded from Regulatory Authority PT-INFARMED-G202101-1626. A 39-year-old male patient received the second dose of bnt162b2 (COMIRNATY, Solution for injection, lot number: EL1484), intramuscular on 20Jan2021 at 30 ug, single for COVID-19 immunisation. Medical history dyslipidemia, hyperuricaemia, gastritis and depressive syndrome/ Depression; Allergy, urticaria, to shrimp, all from an unknown date and unknown if ongoing. Concomitant medications included lansoprazole for Gastritis, escitalopram for Depression, sulpiride (DOGMATIL) for Depression, mexazolam (SEDOXIL). The patient presented perimyocarditis associated with the use of Comirnaty/mRNA vaccine against COVID-19 (with modified nucleoside) concentrate for injectable dispersion, 30ug/0.3ml (lot EL1484) on 2nd use, for immunization against COVID-19 with the posology of 30ug/0.3ml in a single intramuscular administration. The adverse reaction started 2 days after the administration of the suspect medication (22Jan2021). The event resulted in hospitalization. The Specific treatment of the reaction with anti-inflammatory. The event improved with the treatment. A SARS-CoV2 test was performed on 23Jan2021 and the result was negative. The outcome of the event was recovered in 2021. No follow-up attempts are possible. No further information is expected.


VAERS ID: 1051194 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-14
Onset:2021-01-23
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-02-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6797 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Chest pain, Magnetic resonance imaging, Pericarditis, SARS-CoV-2 test
SMQs:, Systemic lupus erythematosus (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Chronic kidney disease (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Flu
Allergies:
Diagnostic Lab Data: Test Name: MRI; Result Unstructured Data: Test Result:excludes that it is a recent pericarditis; Test Date: 202012; Test Name: covid-19 test; Test Result: Negative
CDC Split Type: ITPFIZER INC2021141080

Write-up: retrosternal pain, diagnosis in the emergency room of pericarditis with involvement of the myocardium; retrosternal pain, diagnosis in the emergency room of pericarditis with involvement of the myocardium; This is a spontaneous report from a contactable physician downloaded from the regulatory authority IT-MINISAL02-671518. A 55-year-old male patient received the first dose of bnt162b2 (COMIRNATY, lot: EJ6797, expiration date: 30Apr2021), intramuscular on 14Jan2021 10:55 at single dose for covid-19 immunization. Medical history included flu from Dec2020. The patient''s concomitant medications were not reported. On 23Jan2021 at 12:23 the patient went to emergency room for retrosternal pain where he was diagnosed with pericarditis involving the myocardium. All events were reported as serious as hospitalization. Currently therapy with colchicine, ibuprofen, beta blocker (metoprolol), antihypertensive (ramipril), aspirin and pantoprazole for three months. Currently patient is fine, he is in therapy for three months as set by the emergency room. The cardiologist examining the MRI excludes that it is a recent pericarditis (therefore linked to vaccination) but believes it may be linked to a long flu episode had in December 2020 not due to Covid-19 because the swab was negative. Therapy set as ibuprofen 600 mg x 3die for a week, then x 2 to complete 3 total weeks of treatment, colchicine 0.5 mg BID for three months, metoprolol 25 mg BID, ramipril 2.5 mg in the evening, pantorc 40 mg 1 tablet 8 hours. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.


Result pages: prev   17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=26&SYMPTOMS[]=Acute_endocarditis_%2810049001%29&SYMPTOMS[]=Atypical_mycobacterium_pericarditis_%2810055036%29&SYMPTOMS[]=Autoimmune_myocarditis_%2810064539%29&SYMPTOMS[]=Bacterial_pericarditis_%2810004050%29&SYMPTOMS[]=Carditis_%2810062746%29&SYMPTOMS[]=Endocarditis_%2810014665%29&SYMPTOMS[]=Endocarditis_bacterial_%2810014666%29&SYMPTOMS[]=Endocarditis_enterococcal_%2810014671%29&SYMPTOMS[]=Endocarditis_noninfective_%2810062608%29&SYMPTOMS[]=Endocarditis_staphylococcal_%2810014684%29&SYMPTOMS[]=Endocarditis_viral_%2810061837%29&SYMPTOMS[]=Eosinophilic_myocarditis_%2810014961%29&SYMPTOMS[]=Fungal_endocarditis_%2810017529%29&SYMPTOMS[]=Giant_cell_myocarditis_%2810083635%29&SYMPTOMS[]=Immune-mediated_myocarditis_%2810082606%29&SYMPTOMS[]=Lupus_endocarditis_%2810058225%29&SYMPTOMS[]=Lyme_carditis_%2810078417%29&SYMPTOMS[]=Meningococcal_carditis_%2810027270%29&SYMPTOMS[]=Myocarditis_%2810028606%29&SYMPTOMS[]=Myocarditis_bacterial_%2810065218%29&SYMPTOMS[]=Myocarditis_infectious_%2810066857%29&SYMPTOMS[]=Myocarditis_septic_%2810028615%29&SYMPTOMS[]=Myopericarditis_%2810028650%29&SYMPTOMS[]=Pericarditis_%2810034484%29&SYMPTOMS[]=Pericarditis_constrictive_%2810034487%29&SYMPTOMS[]=Pericarditis_infective_%2810062491%29&SYMPTOMS[]=Pericarditis_lupus_%2810058149%29&SYMPTOMS[]=Pericarditis_meningococcal_%2810034492%29&SYMPTOMS[]=Pericarditis_rheumatic_%2810034496%29&SYMPTOMS[]=Pericarditis_tuberculous_%2810055069%29&SYMPTOMS[]=Pleuropericarditis_%2810059361%29&SYMPTOMS[]=Purulent_pericarditis_%2810051071%29&SYMPTOMS[]=Streptococcal_endocarditis_%2810073742%29&SYMPTOMS[]=Subacute_endocarditis_%2810042276%29&SYMPTOMS[]=Viral_myocarditis_%2810047470%29&SYMPTOMS[]=Viral_pericarditis_%2810047472%29&VAX=COVID19&VAXTYPES=COVID-19&WhichAge=range&LOWAGE=(-1)&HIGHAGE=(-1)


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166